FI102460B1 - Menetelmä N-etoksikarbonyyli-3-morfolinosydnoni-imiinin tai sen suolan ja syklodekstriinin tai syklodekstriinijohdannaisen inkluusiokompleksien valmistamiseksi - Google Patents
Menetelmä N-etoksikarbonyyli-3-morfolinosydnoni-imiinin tai sen suolan ja syklodekstriinin tai syklodekstriinijohdannaisen inkluusiokompleksien valmistamiseksiInfo
- Publication number
- FI102460B1 FI102460B1 FI915569A FI915569A FI102460B1 FI 102460 B1 FI102460 B1 FI 102460B1 FI 915569 A FI915569 A FI 915569A FI 915569 A FI915569 A FI 915569A FI 102460 B1 FI102460 B1 FI 102460B1
- Authority
- FI
- Finland
- Prior art keywords
- cyclodextrin
- ethoxycarbonyl
- beta
- morpholinosydnoneimine
- salt
- Prior art date
Links
- 229920000858 Cyclodextrin Polymers 0.000 title abstract 8
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- XLFWDASMENKTKL-UHFFFAOYSA-N molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 abstract 4
- 239000001116 FEMA 4028 Substances 0.000 abstract 3
- 229960004853 betadex Drugs 0.000 abstract 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract 2
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 abstract 2
- 235000011175 beta-cyclodextrine Nutrition 0.000 abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 abstract 1
- 230000002253 anti-ischaemic effect Effects 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003527 fibrinolytic agent Substances 0.000 abstract 1
- 230000003480 fibrinolytic effect Effects 0.000 abstract 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229960004027 molsidomine Drugs 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/04—1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU186890 | 1990-03-28 | ||
| HU901868A HU210921B (en) | 1990-03-28 | 1990-03-28 | Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them |
| PCT/HU1991/000012 WO1991014680A1 (en) | 1990-03-28 | 1991-03-28 | Inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine or salts formed with cyclodextrin derivatives, preparation thereof and pharmaceutical compositions containing the same |
| HU9100012 | 1991-03-28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI915569A0 FI915569A0 (fi) | 1991-11-26 |
| FI102460B1 true FI102460B1 (fi) | 1998-12-15 |
| FI102460B FI102460B (fi) | 1998-12-15 |
Family
ID=10956592
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI915569A FI102460B (fi) | 1990-03-28 | 1991-11-26 | Menetelmä N-etoksikarbonyyli-3-morfolinosydnoni-imiinin tai sen suolan ja syklodekstriinin tai syklodekstriinijohdannaisen inkluusiokompleks ien valmistamiseksi |
Country Status (34)
| Country | Link |
|---|---|
| US (1) | US5403840A (fi) |
| EP (1) | EP0477315B1 (fi) |
| JP (1) | JP2582497B2 (fi) |
| KR (1) | KR950004705B1 (fi) |
| CN (1) | CN1051080C (fi) |
| AT (1) | ATE138656T1 (fi) |
| AU (1) | AU638824B2 (fi) |
| BG (1) | BG61689B1 (fi) |
| BR (1) | BR9105136A (fi) |
| CA (1) | CA2054188C (fi) |
| CZ (1) | CZ287353B6 (fi) |
| DE (1) | DE69119853T2 (fi) |
| DK (1) | DK0477315T3 (fi) |
| ES (1) | ES2090320T3 (fi) |
| FI (1) | FI102460B (fi) |
| GE (1) | GEP19991832B (fi) |
| GR (1) | GR3020684T3 (fi) |
| HR (1) | HRP920561B1 (fi) |
| HU (1) | HU210921B (fi) |
| IL (1) | IL97714A (fi) |
| LT (1) | LT3394B (fi) |
| LV (1) | LV10245B (fi) |
| MC (1) | MC2185A1 (fi) |
| MD (1) | MD679G2 (fi) |
| NO (1) | NO179611C (fi) |
| OA (1) | OA10029A (fi) |
| PL (1) | PL165868B1 (fi) |
| RO (1) | RO109649B1 (fi) |
| RU (1) | RU2111216C1 (fi) |
| SI (1) | SI9110908A (fi) |
| SK (1) | SK279891B6 (fi) |
| TJ (1) | TJ231R3 (fi) |
| UA (1) | UA27226C2 (fi) |
| WO (1) | WO1991014680A1 (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA949182B (en) * | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| GB2290964A (en) * | 1994-07-08 | 1996-01-17 | Arto Olavi Urtti | Transdermal drug delivery system |
| US6046177A (en) * | 1997-05-05 | 2000-04-04 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations |
| GB9915231D0 (en) | 1999-06-29 | 1999-09-01 | Pfizer Ltd | Pharmaceutical complex |
| FR2805462B1 (fr) * | 2000-02-24 | 2003-08-15 | Therabel Res | Nouvelle forme galenique orale a liberation prolongee de la molsidomine |
| ITTO20120056A1 (it) * | 2012-01-24 | 2013-07-25 | Borla Ind | Connettore per linee medicali di infusione, trasfusione e simili |
| ITTO20130433A1 (it) * | 2013-05-29 | 2014-11-30 | Borla Ind | Connettore per linee medicali |
| BE1028879B1 (fr) | 2020-12-11 | 2022-07-12 | Europharmaceuticals | Comprimé à libération prolongée de la molsidomine |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1695897C3 (de) * | 1966-07-04 | 1979-02-15 | Takeda Chemical Industries Ltd | N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE3221425A1 (de) * | 1982-06-07 | 1983-12-08 | Boehringer Ingelheim KG, 6507 Ingelheim | Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette |
| DK243084A (da) * | 1983-05-26 | 1984-11-27 | Takeda Chemical Industries Ltd | Perkutane farmaceutiske praeparater til udvortes brug |
| DE3346614A1 (de) * | 1983-12-23 | 1985-07-04 | Anton Hummel Gmbh Metallwarenfabrik, 7808 Waldkirch | Entlueftungsventil insbesondere zum entlueften von heizsystemen |
| GB8506792D0 (en) * | 1985-03-15 | 1985-04-17 | Janssen Pharmaceutica Nv | Derivatives of y-cyclodextrin |
| DE3522191A1 (de) * | 1985-06-21 | 1987-01-15 | Cassella Ag | Photostabilisierung von sydnoniminen |
| GB8613688D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| JPH0819004B2 (ja) * | 1986-12-26 | 1996-02-28 | 日清製粉株式会社 | 徐放性医薬製剤 |
| IT1204725B (it) * | 1987-06-17 | 1989-03-10 | Edmond Pharma Srl | Complessi di inclusione del dipiridamolo con ciclodestrine |
| DE68901043D1 (de) * | 1988-01-14 | 1992-04-30 | Akzo Nv | Waessriges pharmazeutisches praeparat. |
| US5120732A (en) * | 1988-06-14 | 1992-06-09 | Cassella Aktiengesellschaft | Substituted 3-aminosyndone imines, a process for their preparation and their use |
| IT1227626B (it) * | 1988-11-28 | 1991-04-23 | Vectorpharma Int | Farmaci supportati aventi velocita' di dissoluzione aumentata e procedimento per la loro preparazione |
| SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
| HU211648A9 (en) * | 1990-03-28 | 1995-12-28 | Chinoin Gyogyszer Es Vegyeszet | Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same |
-
1990
- 1990-03-28 HU HU901868A patent/HU210921B/hu unknown
-
1991
- 1991-03-28 RU SU5010581A patent/RU2111216C1/ru active
- 1991-03-28 CA CA002054188A patent/CA2054188C/en not_active Expired - Lifetime
- 1991-03-28 SI SI9110908A patent/SI9110908A/sl unknown
- 1991-03-28 IL IL9771491A patent/IL97714A/en not_active IP Right Cessation
- 1991-03-28 BR BR919105136A patent/BR9105136A/pt not_active Application Discontinuation
- 1991-03-28 MC MC@@@@D patent/MC2185A1/xx unknown
- 1991-03-28 CN CN91102687A patent/CN1051080C/zh not_active Expired - Fee Related
- 1991-03-28 CZ CS1991851A patent/CZ287353B6/cs not_active IP Right Cessation
- 1991-03-28 US US07/807,852 patent/US5403840A/en not_active Expired - Lifetime
- 1991-03-28 KR KR1019910701670A patent/KR950004705B1/ko not_active Expired - Fee Related
- 1991-03-28 RO RO148827A patent/RO109649B1/ro unknown
- 1991-03-28 AU AU75745/91A patent/AU638824B2/en not_active Expired
- 1991-03-28 DE DE69119853T patent/DE69119853T2/de not_active Expired - Lifetime
- 1991-03-28 EP EP91906726A patent/EP0477315B1/en not_active Expired - Lifetime
- 1991-03-28 SK SK851-91A patent/SK279891B6/sk unknown
- 1991-03-28 AT AT91906726T patent/ATE138656T1/de not_active IP Right Cessation
- 1991-03-28 PL PL91293022A patent/PL165868B1/pl unknown
- 1991-03-28 JP JP3507012A patent/JP2582497B2/ja not_active Expired - Lifetime
- 1991-03-28 WO PCT/HU1991/000012 patent/WO1991014680A1/en not_active Ceased
- 1991-03-28 UA UA5010581A patent/UA27226C2/uk unknown
- 1991-03-28 DK DK91906726.4T patent/DK0477315T3/da active
- 1991-03-28 ES ES91906726T patent/ES2090320T3/es not_active Expired - Lifetime
- 1991-11-08 OA OA60094A patent/OA10029A/en unknown
- 1991-11-26 FI FI915569A patent/FI102460B/fi active
- 1991-11-27 NO NO914649A patent/NO179611C/no not_active IP Right Cessation
- 1991-11-27 BG BG95531A patent/BG61689B1/bg unknown
-
1992
- 1992-09-28 HR HRP-908/91A patent/HRP920561B1/xx not_active IP Right Cessation
- 1992-12-30 LV LVP-92-590A patent/LV10245B/en unknown
-
1993
- 1993-03-05 LT LTIP386A patent/LT3394B/lt not_active IP Right Cessation
- 1993-06-16 GE GEAP1993884A patent/GEP19991832B/en unknown
-
1994
- 1994-08-25 MD MD94-0333A patent/MD679G2/ro not_active IP Right Cessation
- 1994-11-28 TJ TJ94000007A patent/TJ231R3/xx unknown
-
1996
- 1996-07-31 GR GR960402042T patent/GR3020684T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI102460B1 (fi) | Menetelmä N-etoksikarbonyyli-3-morfolinosydnoni-imiinin tai sen suolan ja syklodekstriinin tai syklodekstriinijohdannaisen inkluusiokompleksien valmistamiseksi | |
| RU94028890A (ru) | Композиции производных циклодекстрина, композиции, содержащие лекарство и производные циклодекстринов | |
| CA2074186A1 (en) | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof | |
| TJ275B (en) | Derivatives of cyclodextrins exhibiting enhenced aqueous solubility and the use thereof | |
| HUT62198A (en) | Erythropoietin compositions comprising cyclodextrin | |
| EA199800910A1 (ru) | Композиции, комплексы включения фармацевтически приемлемой соли зипразидона и циклодекстрина и соли зипразидона | |
| AU3854095A (en) | Novel complexes and their compositions | |
| EP0931545A3 (en) | Droloxifene pharmaceutical compositions | |
| EP0274444A3 (en) | Solution inbuprofen complexes, compositions and processes for preparing the same | |
| AU8221291A (en) | Cyclopentane derivatives, process for producing them and their pharmaceutical use | |
| DE59409820D1 (de) | Cyclodextringlycosyltransferasen zur Produktion von gamma-Cyclodextrin | |
| Kawabata et al. | Formation and deposition of monolayers of amphiphilic β-cyclodextrin derivatives | |
| BR0212027A (pt) | Recipiente tendo propriedades organolépticas de barreira melhoradas | |
| ATE71633T1 (de) | Einschlusskomplexe von dipyridamol und cyclodextrinen. | |
| ES2166411T3 (es) | Procedimiento para derivatizar poliglucosaminas. | |
| DE59807141D1 (de) | Polyrotaxane | |
| DE59700117D1 (de) | Cyclodextringlycosyltransferasen zur Produktion von gamma-Cyclodextrin | |
| GR930100342A (el) | Σύμπλοκα εγκλίσεως και φαρμακευτικές συν?έσεις οι οποιές τα περιέχουν. | |
| 刘勇 et al. | Water-soluble crosslinked β-cyclodextrin polymer inclusion complexes with C60 | |
| KR970058709A (ko) | 엘-무스콘(l-muscone)의 포접화합물 및 그의 제조방법 | |
| CA2027773A1 (en) | Treatment of shock by cyclodextrins and their derivatives | |
| ITMI992406A0 (it) | Complessi di paroxetina base con ciclodestrine o derivati delle ciclod estrine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: THERABEL INDUSTRIES S.A. |